Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 262,715 shares of BLFS, which is worth approximately $6.92 Million. The most recent transaction as insider was on Jan 06, 2025, when has been sold 404 shares (Common Stock) at a price of $27.02 per share, resulting in proceeds of $10,916. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

17.17% 3M change

4.58% 12M change

Total Value Held $6.92 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2025	SELL Open market or private sale	$10,916 $27.02 p/Share	404 Reduced 0.15%	262,715 Common Stock
Dec 17 2024	SELL Open market or private sale	$358,403 $27.16 p/Share	13,196 Reduced 4.78%	263,119 Common Stock
Dec 16 2024	SELL Open market or private sale	$207,817 $27.33 p/Share	7,604 Reduced 2.68%	276,315 Common Stock
Nov 26 2024	SELL Open market or private sale	$14,225 $27.2 p/Share	523 Reduced 0.18%	283,919 Common Stock
Nov 18 2024	SELL Open market or private sale	$352,960 $20.05 p/Share	17,604 Reduced 5.83%	284,442 Common Stock
Nov 15 2024	SELL Open market or private sale	$529,250 $21.17 p/Share	25,000 Reduced 7.64%	302,046 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 2.97%	327,046 Common Stock
Nov 12 2024	SELL Open market or private sale	$3,239 $26.34 p/Share	123 Reduced 0.04%	317,046 Common Stock
Oct 30 2024	SELL Open market or private sale	$12,663 $23.15 p/Share	547 Reduced 0.17%	317,169 Common Stock
Oct 16 2024	SELL Open market or private sale	$231,700 $23.17 p/Share	10,000 Reduced 3.05%	317,716 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 2.96%	327,716 Common Stock
Oct 15 2024	SELL Open market or private sale	$232,800 $23.28 p/Share	10,000 Reduced 3.05%	317,716 Common Stock
Oct 15 2024	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 2.96%	327,716 Common Stock
Sep 19 2024	SELL Open market or private sale	$254,700 $25.47 p/Share	10,000 Reduced 3.05%	317,716 Common Stock
Sep 19 2024	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 2.96%	327,716 Common Stock
Sep 18 2024	SELL Open market or private sale	$239,000 $23.9 p/Share	10,000 Reduced 3.05%	317,716 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 2.96%	327,716 Common Stock
Sep 16 2024	SELL Open market or private sale	$8,616 $25.12 p/Share	343 Reduced 0.11%	317,716 Common Stock
Aug 21 2024	SELL Open market or private sale	$2,842 $25.61 p/Share	111 Reduced 0.03%	318,059 Common Stock
Jul 11 2024	SELL Open market or private sale	$6,429 $20.54 p/Share	313 Reduced 0.1%	318,170 Common Stock
May 29 2024	SELL Open market or private sale	$11,260 $21.78 p/Share	517 Reduced 0.16%	318,483 Common Stock
May 17 2024	SELL Open market or private sale	$2,173 $22.18 p/Share	98 Reduced 0.03%	319,000 Common Stock
Apr 18 2024	SELL Open market or private sale	$8,941 $15.31 p/Share	584 Reduced 0.18%	319,098 Common Stock
Mar 27 2024	SELL Open market or private sale	$8,167 $17.99 p/Share	454 Reduced 0.14%	319,682 Common Stock
Mar 12 2024	SELL Open market or private sale	$108,248 $16.6 p/Share	6,521 Reduced 2.0%	320,136 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account